Dr Reddy's in pact with Shanghai Henlius Biotech for exclusive US, Europe rights for daratumumab biosimilar
HYDERABAD: Dr Reddy’s Laboratories SA, the wholly-owned Swiss subsidiary of Hyderabad-based pharma biggie Dr Reddy’s ...
PharmiWeb2d
Hypercalcemia Treatment Market Set for Rapid Expansion with Advancements in Diagnosis and Drug Development
Hypercalcemia Treatment MarketThe global hypercalcemia treatment market is on track for significant growth, with an estimated valuation of USD 18.07 billion in 2023. The market is projected to expand ...
Amgen Profit Beats Estimates, Next MariTide Studies Start by Mid-Year
Amgen investors have been focused on prospects for MariTide, which activates the appetite- and blood sugar-reducing hormone ...
UBS downgrades Sandoz to 'neutral,' citing limited upside in Biosimilar growth
UBS forecasts that Sandoz will likely achieve the lower end of its 24-26% core EBITDA margin target by 2028. To reach the ...
centerforbiosimilars6d
Understanding Biosimilars Through Education and PBM Formulary Perspective
Josh Canavan, PharmD, head of pharmacy at RazorMetrics, recommends key educational resources for biosimilars, and emphasizes the extensive research conducted before pharmacy benefit managers (PBMs) ...